Researchers at the Carney Institute for Brain Science have identified electrical activity in the brain that could predict ...

The Cleveland bank is working with Personetics to provide advice and help to digital banking customers that takes into ...

Blarcamesine appeared to slow the decline of cognition and functional capacity for people with Alzheimer’s disease in a ...

Dementia with Lewy bodies (DLB), the second most common type of dementia, requires a multifactorial approach to reduce symptoms.

Blarcasemine met its primary endpoints, improving cognition and function over a four year period in early-stage Alzheimer’s patients.